Almirall partners with CrystalO to develop small molecules for medical dermatology
Sobi partners with Innate Pharma to advance lacutamab in T-cell lymphoma
Saniona grants AstronauTx worldwide rights to neurological disease programme
Oculis signs agreement to acquire Privosegtor from Accure Therapeutics
Biophytis receives Brazilian approval for Phase 2 obesity trial of BIO101
ImmuPharma selects Kymos Group as bioanalytical partner for Kapiglucagon
Neurocrine Biosciences initiates Phase 1 study of GLP-1/GIP/glucagon receptor triple agonist
Akeso Advances reports first patient dosed in AK146D1 combined with ivonescimab breast cancer study
Alebund's AP301 NDA accepted for review by China's NMPA
BioInvent receives FDA Fast Track designation for BI-1808 in ovarian cancer
NeuroSense completes PrimeC Pre-NDS process for potential December 2026 filing with Health Canada
Roche expands cyclospora testing portfolio to support US public health response
Olio Labs reveals study demonstrating AI-driven in vivo platform can predict clinical trial outcomes
Innovent doses first colorectal cancer patient with IBI363/TAK-928 in combination with bevacizumab